Chaga
Inonotus obliquus
Antioxidant positioning — weak human evidence; prominent kidney-safety caution required.
Important: Chaga is very high in oxalates. Avoid entirely for customers with kidney stones or kidney disease. Case reports link high-dose, prolonged use to kidney injury.
What the evidence shows
Chaga is famous for extremely high antioxidant (ORAC) values in lab testing and a long traditional-use history in Siberia and Northern Europe. Human clinical evidence is essentially absent — almost everything published is lab, animal data, or case reports. Brands launching chaga should treat antioxidant positioning as traditional and speculative, not trial-confirmed.
NutraLabel summarizes published research for formulation planning only. We make no health, disease, or efficacy claims about finished products.
Active compounds
Polyphenols, melanin, betulinic acid, polysaccharides
Primary positioning angle: antioxidant/anti-inflammatory, immune support (traditional positioning).
Format fit & formulation notes
Chaga is earthy and bitter — workable in chocolate with strong flavor masking, or in capsules where taste is less of a constraint. Any brand launching chaga should plan prominent oxalate cautions on packaging, product pages, and marketing — not buried in fine print. We can formulate chaga, but recommend conservative dosing and clear consumer warnings.
Typical dose range (as studied)
No well-established therapeutic dose in humans. Case reports of kidney injury involved high doses (~10–15 g/day) taken long-term. If used at all, conservative amounts only.
Cautions
Chaga is very high in oxalates. Avoid entirely for customers with kidney stones or kidney disease. Case reports link high-dose, prolonged use to kidney injury.
Chaga is very high in oxalates. Documented case reports link high-dose, prolonged use to oxalate nephropathy (kidney injury). Avoid entirely for customers with any history of kidney stones or kidney disease. Avoid combining with high-dose vitamin C. May affect blood sugar and blood clotting. Hydration and dose discipline matter.
Claims defensibility
Antioxidant positioning is common but human evidence is weak. Kidney-risk cautions must be prominent on the label and in marketing. NutraLabel recommends brands discuss chaga positioning with regulatory counsel before launch.
Antioxidant and traditional-use language, paired with prominent oxalate/kidney cautions.
Disease-treatment or 'detox' claims, positioning as risk-free, or omitting kidney-safety cautions.
These are general guides, not legal advice. See our quality & compliance overview and work with your regulatory advisor before finalizing label copy.
References
Selected sources behind the evidence summary above. Verify specifics against the primary source before relying on them; research in this field is evolving.
- Chaga-induced oxalate nephropathy — case report (PMC) · Clinical / peer-reviewed
Formulate a chaga product under your brand
Tell us the mushroom, format, and positioning. We develop the formula and manufacture finished chocolate, gummies, or capsules under your label.
These statements have not been evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. Educational content only — not medical or regulatory advice.
Questions, answered.
Is chaga safe to put in a consumer supplement?
It can be formulated, but kidney-safety risk is real at high or prolonged doses. Brands must surface oxalate cautions clearly and avoid positioning chaga as a no-risk antioxidant. Conservative dosing and regulatory review are essential.
Why is chaga risky compared to other mushrooms?
Oxalate content. Case reports document kidney injury linked to high-dose, long-term chaga use — sometimes combined with vitamin C. The risk-to-benefit ratio is unfavorable relative to mushrooms with better human evidence.
Can you put chaga in functional chocolate?
Yes, with flavor masking and conservative dose targets. We recommend pairing formulation with prominent consumer warnings about kidney history and avoiding high-dose vitamin C combinations.
What claims can my chaga brand make?
Antioxidant and traditional-use language is common, but human trial support is weak. Avoid disease-treatment claims. Your regulatory advisor should review all label copy — especially cautions.